Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
107.16
Dollar change
+0.08
Percentage change
0.07
%
IndexS&P 500 P/E176.48 EPS (ttm)0.61 Insider Own0.63% Shs Outstand251.00M Perf Week0.84%
Market Cap26.41B Forward P/E13.80 EPS next Y7.77 Insider Trans-9.89% Shs Float244.93M Perf Month14.51%
Income156.00M PEG10.19 EPS next Q1.59 Inst Own88.96% Short Float / Ratio3.35% / 3.99 Perf Quarter22.36%
Sales210.17B P/S0.13 EPS this Y20.13% Inst Trans0.13% Short Interest8.21M Perf Half Y26.68%
Book/sh-14.13 P/B- EPS next Y11.65% ROA0.36% Target Price106.44 Perf Year33.67%
Cash/sh15.64 P/C6.85 EPS next 5Y17.32% ROE- 52W Range68.53 - 107.16 Perf YTD39.40%
Dividend2.04 P/FCF9.24 EPS past 5Y4.23% ROI39.10% 52W High0.00% Beta0.82
Dividend %1.91% Quick Ratio0.50 Sales past 5Y8.47% Gross Margin3.25% 52W Low56.37% ATR1.71
Employees48000 Current Ratio0.99 Sales Q/Q10.40% Oper. Margin0.95% RSI (14)72.00 Volatility1.20% 1.95%
OptionableYes Debt/Eq- EPS Q/Q-95.04% Profit Margin0.07% Rel Volume0.79 Prev Close107.08
ShortableYes LT Debt/Eq- EarningsNov 03 BMO Payout199.53% Avg Volume2.06M Price107.16
Recom2.69 SMA203.42% SMA5011.74% SMA20022.68% Volume1,617,459 Change0.07%
Date Action Analyst Rating Change Price Target Change
Jul-10-23Downgrade Evercore ISI Outperform → In-line $100
Mar-31-23Initiated Citigroup Neutral $77
Feb-03-23Upgrade Robert W. Baird Neutral → Outperform $87 → $94
Nov-04-22Upgrade BofA Securities Underperform → Neutral $64 → $80
Aug-22-22Resumed Morgan Stanley Overweight $70 → $76
May-26-22Downgrade Barclays Overweight → Equal Weight
May-18-22Upgrade Evercore ISI In-line → Outperform $55 → $68
Apr-12-22Upgrade Morgan Stanley Equal-Weight → Overweight $74
Apr-01-22Resumed Credit Suisse Neutral $58
Aug-06-21Downgrade Deutsche Bank Buy → Hold $62 → $51
Dec-01-23 04:10PM
04:00PM
Nov-29-23 01:04PM
Nov-27-23 09:15AM
Nov-26-23 06:51AM
12:45PM Loading…
Nov-24-23 12:45PM
06:11AM
Nov-23-23 09:40AM
08:51AM
Nov-20-23 11:37PM
12:43PM
12:19PM
Nov-15-23 05:39AM
Nov-14-23 04:10PM
Nov-13-23 09:48PM
07:44AM Loading…
Nov-10-23 07:44AM
Nov-09-23 07:30AM
Nov-08-23 09:15AM
Nov-07-23 12:45PM
09:40AM
Nov-04-23 11:19AM
Nov-03-23 10:45PM
05:05PM
04:25PM
02:37PM
09:35AM
09:30AM
08:45AM
08:45AM
07:33AM
07:03AM Loading…
07:03AM
06:55AM
Nov-02-23 10:20AM
10:00AM
08:30AM
Nov-01-23 04:58PM
01:24PM
07:47AM
Oct-31-23 04:01AM
Oct-30-23 10:00AM
05:46AM
Oct-27-23 10:00AM
Oct-26-23 01:45PM
Oct-25-23 05:15PM
09:40AM
Oct-24-23 11:02AM
02:18AM
Oct-23-23 09:15AM
Oct-18-23 11:10AM
11:05AM
10:59AM
10:57AM
10:50AM
10:10AM
07:45AM
Oct-17-23 11:32AM
11:17AM
10:08AM
10:04AM
10:03AM
08:33AM
08:07AM
05:57AM
Oct-16-23 10:39AM
10:38AM
08:43AM
08:28AM
Oct-14-23 07:45AM
Oct-13-23 10:05AM
08:28AM
Oct-12-23 12:04PM
11:58AM
08:33AM
Oct-11-23 09:40AM
09:40AM
08:08AM
07:07AM
Oct-09-23 09:40AM
Oct-06-23 09:50AM
Oct-04-23 08:08PM
Oct-03-23 08:56AM
Oct-02-23 07:02AM
Sep-28-23 08:00AM
06:14AM
Sep-27-23 12:33PM
07:35AM
Sep-26-23 06:55AM
Sep-18-23 09:40AM
Sep-15-23 09:50AM
Sep-14-23 11:30AM
Sep-13-23 09:00AM
Sep-11-23 08:53AM
Sep-08-23 08:36AM
Sep-06-23 02:46PM
Sep-01-23 09:40AM
Aug-31-23 12:14PM
Aug-30-23 08:00AM
Aug-29-23 11:38AM
Aug-27-23 05:43PM
Aug-25-23 02:46PM
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEITZMAN DEBORAHCEO, Pharmaceutical SegmentNov 27Option Exercise74.1027,6422,048,35671,844Nov 29 09:14 AM
WEITZMAN DEBORAHCEO, Pharmaceutical SegmentNov 27Sale106.3136,6423,895,41135,202Nov 29 09:14 AM
WEITZMAN DEBORAHCEO, Pharmaceutical SegmentAug 28Option Exercise71.436,712479,43850,914Aug 29 04:21 PM
WEITZMAN DEBORAHCEO, Pharmaceutical SegmentAug 28Sale89.816,712602,80544,202Aug 29 04:21 PM
Scherer Mary C.Chief Accounting OfficerAug 18Option Exercise75.3611,460863,64631,344Aug 21 04:16 PM
Scherer Mary C.Chief Accounting OfficerAug 18Sale86.2720,6951,785,35810,649Aug 21 04:16 PM
Snow Ola MChief Human Resources OfficerAug 17Option Exercise71.433,907279,07752,086Aug 17 07:47 PM
Mason Stephen MCEO, Medical SegmentAug 17Sale87.3237,5003,274,64237,355Aug 17 07:52 PM
Snow Ola MChief Human Resources OfficerAug 17Sale87.4126,3242,301,05325,762Aug 17 07:47 PM
Mayer Jessica LChief Legal/Compliance OfficerAug 17Sale87.6810,668935,37084,865Aug 17 07:57 PM
Greene Michelle D.Chief Information OfficerAug 17Sale86.792,000173,58020,814Aug 17 07:49 PM
Mayer Jessica LChief Legal/Compliance OfficerAug 16Option Exercise77.342,115163,568125,678Aug 17 07:57 PM
Mayer Jessica LChief Legal/Compliance OfficerAug 16Sale90.8430,1452,738,37295,533Aug 17 07:57 PM
Mayer Jessica LChief Legal/Compliance OfficerAug 07Option Exercise51.4981341,861130,917Aug 08 07:45 PM